Navigation Links
VIVUS Reports First Quarter 2011 Financial Results
Date:5/2/2011

with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com.

Note to Investors As previously announced, VIVUS will hold a conference call and an audio webcast to discuss the first quarter financial results today, May 2, 2011, beginning at 1:30 p.m. Pacific Time. Investors can listen to this call by dialing 1-877-359-2916 and outside the U.S. 1-224-357-2386. A webcast replay will be available for 30 days and can be accessed at http://ir.vivus.com/.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate" and "intend," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the timing and substance of our response to the FDA's requests from the End of Review meeting; our response to, and continued dialogue with, the FDA relating to matters raised in the FDA's CRL; the timing and results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy; the FDA's interpretation of and agreement with the information VIVUS submitted and may submit relating to teratogenicity and cardiovascular safety; the FDA's interpretation of the data from our SEQUEL study, or OB-305; the FDA's requests, if any, to conduct additional prospective studies or retrospective observational studies or to provide further analysis of clinical trial data; the review and questions from the EMA and CHMP on the MAA; substantial competition; the impact on future sales based on specific indication and contraindicati
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. VIVUS to Present at Four Upcoming Investor Conferences in May
2. VIVUS to Present at the 10th Annual Needham Healthcare Conference
3. Data on VIVUS QNEXA to be Presented in Six Posters at The Obesity Societys Annual Meeting
4. VIVUS to Present at Four Upcoming Investor Conferences
5. VIVUS to Present at Two Upcoming Investor Conferences
6. VIVUS Reports Third Quarter 2009 Highlights and Financial Results
7. VIVUS Announces Positive Results From Two Phase 3 Studies; Obese Patients on Qnexa Achieve Average Weight Loss up to 14.7% and Significant Improvements in Co-Morbidities
8. VIVUS to Present at Four Upcoming Healthcare Conferences
9. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
10. VIVUS to Present at the Needham and Company Life Sciences Conference
11. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014 Draper University, a top ... to announce that for 6 weeks this summer, ... converge on the Draper University campus in the ... program focused on entrepreneurship, building real-world skills, and ... running its sixth cohort, continues to refresh its ...
(Date:7/24/2014)... 2014 The patent provides substantially ... test results. It also enables true sample ID ... and reporting of high profile assays such as ... rapidly growing area of biotechnology that includes DNA ... and companion diagnostics in personalized medicine. The new ...
(Date:7/23/2014)... strides in saving China,s endangered national treasure, the giant ... panda reserves that have been established and three large ... remain in the wild. , Breeding programs in ... by improving genetic diversity, avoid inbreeding and ultimately, introduce ... high-profile programs doing so far? , In a new ...
(Date:7/23/2014)... July 23, 2014  AuraSense Therapeutics, the pioneer ... gene regulatory and immunotherapeutic agents, announced today ... AuraSense Therapeutics, executive leadership team as chief ... Prior to joining AuraSense Therapeutics, Mr. Snyder ... Officer of Cellular Dynamics International Inc., where ...
Breaking Biology Technology:Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 2Summer Entrepreneurship Program Kicked Off by Draper University in Silicon Valley 3New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2
... July 15 Cytomedix Inc (GTF) announces the following Webcast: , , ... 2010 Presentation , , , ... , Where:   http://www.investorcalendar.com/ClientPage.asp?ID=160316 , ... the Internet -- Simply log on to the web at the address above. , ...
... ROCKVILLE, Md. , July 15 MacroGenics, ... to treat autoimmune disorders, cancer and infectious diseases, today ... awarded the company three new grants representing total funding ... MacroGenics further advance its Dual-Affinity Re-Targeting (DART), or bispecific ...
... , July 14 ETEX Corporation, an advanced ... non-exclusive distribution agreement with Stryker,s Spine division to market and ... Generate bone graft substitute products. Both products utilize ETEX,s proprietary ... exclusively manufactured by ETEX Corporation. , ...
Cached Biology Technology:Webcast Alert: Cytomedix Inc (GTF) Announces the LHA Life Sciences & Med Tech Day 2010 Presentation 2MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio 2MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio 3MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio 4ETEX Corporation Announces Distribution Agreement With Stryker 2
(Date:7/24/2014)... theres a virus living inside your gut that has ... led by researchers at San Diego State University has ... host to a newly described virus, named crAssphage, which ... bacteria, Bacteroidetes . This phylum of bacteria is ... gut-related diseases. The research appears today in Nature ...
(Date:7/23/2014)... that early reading skill might positively affect later intellectual ... , was conducted by researchers at the University of ... an ability that can be improved, our findings have ... research fellow in psychology at the University of Edinburgh, ... might aid not only the growth of literacy, but ...
(Date:7/23/2014)... Agency (EPA) today announced that environmental health scientist ... School of Public Health and Health Sciences (SPHHS) ... Results (STAR) grant to measure indoor air quality ... subarctic North America to determine possible health effects ... recommendations for mitigation. , Peltier, who will lead ...
Breaking Biology News(10 mins):Newly discovered gut virus lives in half the world's population 2Newly discovered gut virus lives in half the world's population 3Stronger early reading skills predict higher intelligence later 2Studying impacts of indoor air pollution on tribal communities 2Studying impacts of indoor air pollution on tribal communities 3
... the major driving force in a baby’s development is ... teamwork. , Biologists at The University of Manchester say ... for supremacy in their unborn offspring fails to answer ... In fact, rather than a parental power struggle, the ...
... previously used as a marker in tracing human migration ... Results of this study also suggest that some viruses ... previously thought. , "The most genetically divergent human populations ... at Penn State's Center for Infectious Disease Dynamics. "But, ...
... twist on the slogan “milk does a body good,?radiologists ... contrast agent in gastrointestinal imaging exams—with excellent results. The ... of the Radiological Society of North America (RSNA). , ... enhancement as we see with the commonly used contrast ...
Cached Biology News:Parental genes do what's best for baby 2Viral marker of human migration suspect 2Got inexpensive contrast agent? Milk plays new role in imaging 2
... Agarose-HR High Resolution - ... from 50 to 1000 ... for sizing PCR fragments, ... by restriction enzyme digestion, ...
...
Immunogen: MBP-fusion protein of the C-terminal region of the a2 subunit (amino acids K581-D670) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Replacement Parts for Electrophoresis Apparatus...
Biology Products: